How Has The Size And Value Of The Microfluidic Devices Market Changed During The 2026–2030 Period?
The microfluidic devices market size has grown rapidly in recent years. It will grow from $10.14 billion in 2025 to $11.72 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to limited microfabrication techniques, high cost of early microfluidic devices, reliance on traditional fluid handling methods, growing pharmaceutical and biotech research, adoption of basic lab-on-a-chip applications.
The microfluidic devices market size is expected to see rapid growth in the next few years. It will grow to $20.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to advancements in microfabrication and 3D printing, rising demand for point-of-care diagnostics, integration of sensors and actuators with microfluidic platforms, increasing investment in precision medicine research, expansion of high-throughput screening applications. Major trends in the forecast period include rising adoption of lab-on-a-chip and digital microfluidic devices, integration of advanced microfluidic sensors for diagnostics, increased use of microfluidic platforms in pharmaceutical research, growth in polymer and silicon-based microfluidic materials, enhanced focus on miniaturization and high-throughput fluid handling.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Microfluidic Devices Market?
The rising prevalence of infectious diseases is expected to propel the growth of the microfluidic devices market going forward. Infectious diseases are disorders caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites. The prevalence of infectious diseases is due to pathogen characteristics, environmental factors, human behavior, and availability of medical services. Microfluidic devices are a powerful tool in the fight against infectious diseases due to their ability to handle and analyze small volumes of biological samples with high precision and efficiency. It enhances the ability to detect, diagnose, and manage infectious diseases efficiently and accurately, contributing to better health outcomes and disease control. For instance, in November 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2025, 266,165 CHIKVD cases and 118 deaths were reported, a 35.2% decline from 2024, with Brazil in South America most affected. Therefore, the rising prevalence of infectious diseases drives the growth of the microfluidic devices market.
Which Primary Segments Are Included In The Detailed Analysis Of The Microfluidic Devices Market?
The microfluidic devices market covered in this report is segmented –
1) By Device Type: Chips, Sensors, Other Device Types
2) By Material: Glass, Silicon, Polymer, Other Materials
3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Diagnostic Centers, Healthcare Facilities, Other End-Users
Subsegments:
1) By Chips: Lab-On-A-Chip (LoC) Devices, Digital Microfluidic Chips, Microfluidic Flow Control Chips, Integrated Microfluidic Platforms, Diagnostic Microfluidic Chips
2) By Sensors: Pressure Sensors, Flow Sensors, Temperature Sensors, Chemical Sensors, Optical Sensors
3) By Other Device Types: Microfluidic Pumps, Valves And Actuators, Microarray Devices, Microfluidic Analytical Devices, Microfluidic Bioreactors
What Trends Are Driving Change Across The Microfluidic Devices Market Landscape?
Major companies operating in the microfluidic devices market are focused on developing innovative platforms, such as microfluidic chip-based platforms, to streamline and automate complex laboratory processes, enhance the precision and efficiency of experiments, and enable a wide range of applications. A microfluidic chip-based platform is a miniaturized device combining multiple laboratory functions onto a single chip to control and analyze small volumes of fluids precisely. For instance, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, launched the Intabio ZT system, the first fully integrated microfluidic chip-based platform. It is the first fully-integrated microfluidic chip-based platform that combines imaged capillary isoelectric focusing (icIEF) separation and UV detection. The system utilizes the Biologics Explorer software, which enhances data processing capabilities, allowing for a deeper understanding of the biopharmaceuticals being analyzed.
Which Major Corporations Play A Crucial Role In The Microfluidic Devices Market Landscape?
Major companies operating in the microfluidic devices market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Technologies Incorporated, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Zeon Corporation, Standard BioTools Inc., Biosurfit SA, Blacktrace Holdings Ltd., LioniX International B.V., CMC Microsystems Inc., Micronit Microfluidics B.V., Sphere Fluidics Limited, Microfluidic ChipShop GmbH, BlackHole Lab Inc., Bartels-Mikrotechnik GmbH, Hesperos Inc., Fluigent SA
Get Your In-Depth Microfluidic Devices Market Report Now:
Which Regions Demonstrate The Highest Growth Momentum In The Microfluidic Devices Market?
North America was the largest region in the microfluidic devicess market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the microfluidic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment